Metly

Metly is a pharmaceutical competitive intelligence and business development platform that helps pharma and biotech teams monitor markets, evaluate opportunities, and track changes across drug pipelines and portfolios. It brings together internal information and external data from clinical trials, regulatory filings, patents, registrations, conference coverage, market signals, and industry databases in one connected workspace.

The platform supports BD&L intelligence, deal screening, asset discovery, portfolio monitoring, competitive landscape analysis, and pipeline tracking. Users can search for potential licensing and partnership opportunities using plain-language queries, identify relevant assets across fragmented market signals, and prioritize opportunities by therapeutic area, formulation, development stage, or strategic fit.

Metly also monitors competitors and surfaces alerts when important events occur, such as clinical trial updates, regulatory activity, new market entries, or pipeline changes. Each signal is presented with strategic context and potential implications for a company’s portfolio. Automated outputs can help maintain competitive trackers, landscape analyses, reports, and presentation materials as new information becomes available.

Designed for pharmaceutical strategy, business development, licensing, competitive intelligence, and portfolio management teams, Metly provides a centralized way to connect data, monitor market dynamics, and support evidence-based decision-making across the life sciences industry.

Disclaimer: WebCatalog is not affiliated, associated, authorized, endorsed by or in any way officially connected to Metly. All product names, logos, and brands are property of their respective owners.